The Blog

More details available on Eli Lilly clinical study

Clusterbusters has been informed by Eli Lilly and Company that additional details regarding their clinical study in patients with episodic cluster headache have now been posted on clinicaltrials.gov. (see below for website).  Please note that investigator sites (doctor’s offices conducting the study) will continue to be added to clinicaltrials.gov as they become approved by ethics committees over the next few months.  You will receive another communication from Clusterbusters (late April), when enrollment for this clinical study begins.  At that time, if you are interested in participating in the study, you will have the option to complete a questionnaire to help determine whether you may qualify for the study.

Additional details on the chronic cluster headache study will be available on clinicaltrials.gov in April.   You will receive another communication from Clusterbusters in June when enrollment for this clinical study begins.  At that time, if you are interested in participating in the study, you will have the option to complete a questionnaire to help determine whether you may qualify for the study.

Please visit the following site for more details:

https://clinicaltrials.gov/ct2/show/NCT02397473?term=LY2951742&rank=3

ClinicalTrials.gov Identifier:

NCT02397473

A Study of LY2951742 in Participants With Episodic Cluster Headache

Please see the original post for reference: Breaking News: Cluster Headache Study

Comments